Co-Diagnostics Inc (LTS:0A50)
$ 1.27 -0.04 (-3.05%) Market Cap: 40.21 Mil Enterprise Value: -2.09 Mil PE Ratio: 0 PB Ratio: 0.56 GF Score: 49/100

Q3 2020 Co-Diagnostics Inc Earnings Call Transcript

Nov 16, 2020 / 09:30PM GMT
Release Date Price: $14.16 (-15.31%)
Operator

Good afternoon, and welcome to the Co-Diagnostics Third Quarter 2020 Earnings Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Investor Relations. Please go ahead.

Unidentified Company Representative

Thank you, everyone, for joining us today. Before we begin, we would like to inform listeners that certain statements made by Co-Diagnostics during the course of this call may constitute forward-looking statements. Any statement about company expectations, beliefs, plans, objectives, assumptions of future events or performance are forward-looking statements. For example, statements concerning 2020 financial operational guidance, the development, regulatory clearance, commercialization and features of new products, plans and objectives of management and market trends are all forward-looking statements. The company believes these statements are based on reasonable assumptions. However, these statements are not guarantees of performance and involve known and unknown risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot